Transport activity of the high-affinity monocarboxylate transporter MCT2 is enhanced by extracellular carbonic anhydrase IV but not by intracellular carbonic anhydrase II. (33/40)

Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma. (34/40)

Carbonic anhydrases III and IV autoantibodies in rheumatoid arthritis, systemic lupus erythematosus, diabetes, hypertensive renal disease, and heart failure. (35/40)

Function of carbonic anhydrase IX in glioblastoma multiforme. (36/40)

GPI-anchored carbonic anhydrase IV displays both intra- and extracellular activity in cRNA-injected oocytes and in mouse neurons. (37/40)

Quantification of carbonic anhydrase gene expression in ventricle of hypertrophic and failing human heart. (38/40)

Extramitochondrial domain rich in carbonic anhydrase activity improves myocardial energetics. (39/40)

Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial. (40/40)

• 1
• 2
• 3
• 4
• 5